STOCK TITAN

Lixte Biotechnology Holdings, Inc. to Present at August 20th Virtual Investor Summit Microcap Event

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT), a clinical-stage pharmaceutical company specializing in cancer drug development, is set to participate in the Q3 Investor Summit on August 20th, 2024. The event, focused on 50 micro-cap companies with catalysts or strong market performance, will feature Lixte's presentation at 2:00 pm ET.

Investors can access the presentation via a live webcast. Throughout the day, Lixte will also be available for one-on-one meetings with interested parties. This summit provides an opportunity for qualified investors to engage with promising micro-cap companies, offering live Q&A sessions and in-depth discussions.

Loading...
Loading translation...
Argus Session date unavailable
-3.33% session move Open Argus
Details

News Market Reaction – LIXT

The recorded move for LIXT in the trading session of this news was -3.33%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NEW YORK, NY / ACCESSWIRE / August 14, 2024 / Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) is a clinical-stage pharmaceutical company focused on new targets for cancer drug development and developing and commercializing cancer therapies. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.

Event: Q3 Investor Summit
Date: August 20th, 2024
Presentation Time: 2:00 pm ET
Location: https://www.webcaster4.com/Webcast/Page/3062/51117

  • The theme is 50 micro-cap companies with a catalyst and/or strong performance in the current market.

  • Take a deep dive with the best Investors in MicroCap

  • Live Q & A

  • Complimentary to Qualified Investors. Please REGISTER HERE.

About the Investor Summit
The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. Founded in 2015.

Contact:
Fred Rockwell
fred@investorsummitgroup.com
Investor Summit Group

SOURCE: Lixte Biotechnology Holdings, Inc.







View the original press release on accesswire.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Lixte Biotechnology Holdings (LIXT) presenting at the Q3 Investor Summit?

Lixte Biotechnology Holdings (LIXT) is presenting at the Q3 Investor Summit on August 20th, 2024, at 2:00 pm ET.

What is the focus of Lixte Biotechnology Holdings (LIXT)?

Lixte Biotechnology Holdings (LIXT) is a clinical-stage pharmaceutical company focused on developing new targets for cancer drug development and commercializing cancer therapies.

How can investors access Lixte Biotechnology's (LIXT) presentation at the Q3 Investor Summit?

Investors can access Lixte Biotechnology's (LIXT) presentation via a live webcast at https://www.webcaster4.com/Webcast/Page/3062/51117.

Will Lixte Biotechnology (LIXT) be available for one-on-one meetings at the Q3 Investor Summit?

Yes, Lixte Biotechnology (LIXT) will be available for one-on-one meetings throughout the day of the Q3 Investor Summit on August 20th, 2024.

What is the theme of the Q3 Investor Summit featuring Lixte Biotechnology (LIXT)?

The theme of the Q3 Investor Summit is 50 micro-cap companies with a catalyst and/or strong performance in the current market.

Keep reading